Listed

Rand Capital Corp: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 10, 2021 and accepted by EDGAR at May 10, 2021, 08:00 ET.

Share

Management's discussion and analysis

As filed, 31,953 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the consolidated financial statements and related notes included elsewhere in this report. Historical results and percentage relationships among any amounts in the consolidated financial statements are not necessarily indicative of trends in operating results for any future periods.

FORWARD LOOKING STATEMENTS

Statements included in this Management’s Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this report that do not relate to present or historical conditions are “forward-looking statements” within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and in Section 21E of the Securities Exchange Act of 1934, as amended. Additional oral or written forward-looking statements may be made by us from time to time, and forward-looking statements may be included in documents that are filed with the SEC. Forward-looking statements involve risks and uncertainties that could cause our results or outcomes to differ materially from those expressed in the forward-looking statements. Forward-looking statements may include, without limitation, statements relating to our plans, strategies, objectives, expectations and intentions, including statements related to our investment strategies, the impact of COVID-19 on our portfolio companies, our intention to elect U.S. federal tax treatment as a RIC for the 2020 tax year and the associated impact of such election on payment of corporate level taxes by Rand, statements regarding our liquidity and financial resources; statements regarding any Capital Gains Fee that may be due to RCM upon a hypothetical liquidation of our portfolio, and statements regarding future dividend payments, and are intended to be made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “believes,” “forecasts,” “intends,” “possible,” “expects,” “estimates,” “anticipates,” or “plans” and similar expressions are intended to identify forward-looking statements. Among the important factors on which such statements are based are assumptions concerning the scope of the impact of the COVID-19 pandemic and its specific impact on our portfolio companies, the state of the United States economy and the local markets in which our portfolio companies operate, the state of the securities markets in which the securities of our portfolio companies could be traded, liquidity within the United States financial markets, and inflation. Forward-looking statements are also subject to the risks and uncertainties described under the caption “Risk Factors” contained in Part II, Item 1A of this report and in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020.

There may be other factors not identified that affect the accuracy of our forward-looking statements. Further, any forward-looking statement speaks only as of the date when it is made and, except as required by law, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time that may cause our business not to develop as we expect, and we cannot predict all of them.

Overview

We are an externally managed investment company that lends to and invests in lower middle market companies. Our investment objective is to generate current income and when also possible, capital appreciation, by targeting investment opportunities with favorable risk-adjusted returns. Our investment activities are managed by our investment adviser, Rand Capital Management, LLC (“RCM”).

We have elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). As a BDC, we are required to comply with certain regulatory requirements specified in the 1940 Act. Historically, we made the majority of our investments through our wholly owned subsidiary, Rand Capital SBIC, Inc. (“Rand SBIC”), which operates as a small business investment company (“SBIC”) and has been licensed by the U.S. Small Business Administration (“SBA”) since 2002. With the capital raised in 2019 through our stock sale to East Asset Management (“East”) we now also have liquidity at Rand Capital Corporation, the parent company, with which to make investments.

In November 2019, Rand completed a stock sale transaction (the “Transaction”) with East. The Transaction consisted of a $25 million investment in Rand by East, in exchange for approximately 8.3 million shares of Rand common stock. The consideration paid by East for the shares of Rand common stock was comprised of $15.5 million of cash and $9.5 million of portfolio assets. Concurrent with the closing of the transaction with East on November 8, 2019, Rand entered into an investment advisory and management agreement (the “Prior Investment Management Agreement”) and an administration agreement (the “Prior Administration Agreement”) with RCM. In connection with retaining RCM as our investment adviser and administrator, Rand’s management and staff became employees of RCM.

On December 16, 2020, Rand’s shareholders approved a new investment advisory and management agreement (the “Investment Management Agreement”) with RCM at a special meeting of shareholders (the “Special Meeting”). The approval was required because Callodine Group, LLC (“Callodine”), an entity controlled by James Morrow, planned to acquire a controlling interest in RCM, which was then-currently majority owned by East. Section 15(a)(4) of the 1940 Act provides that any investment management contract, such as the Prior Investment Management Agreement, terminates automatically upon its “assignment.” Section 2(a)(4) of the 1940 Act provides that the transfer of a controlling interest of an investment adviser, such as East’s transfer of its controlling interest in RCM to Callodine (the “Adviser Change in Control”), constitutes an “assignment.” The terms of the Investment Management Agreement are identical to those contained in the Prior Investment Management Agreement, with RCM continuing to provide investment advisory and management services to Rand following the Adviser Change in Control. The terms of the Administration agreement are identical to those contained in the Prior Administration Agreement. Following approval by Rand’s shareholders at the Special Meeting, Rand, on December 31, 2020, entered into the Investment Management Agreement and a new administration agreement (the “Administration Agreement”) with RCM and terminated the Prior Administration Agreement.

Pursuant to the terms of the Investment Management Agreement, Rand pays RCM a base management fee and may pay an incentive fee if specified benchmarks are met. In connection with retaining RCM as our investment adviser and administrator, Rand’s management and staff became employees of RCM, a registered investment adviser that has been retained by Rand as its external investment adviser.

We intend to elect U.S federal tax treatment as a regulated investment company (“RIC”) as of January 1, 2020, under subchapter M of the Internal Revenue Code of 1986, as amended, on our timely filed U.S. Federal tax return for the 2020 tax year. To maintain our qualification as a RIC, we must, among other things, meet certain source of income and asset diversification requirements. As of March 31, 2021, we are in compliance with the RIC requirements. As a RIC, we generally will not be subject to corporate-level U.S. federal income taxes on any net ordinary income or capital gains that we timely distribute to our shareholders as dividends.

In connection with the preparation for our RIC election, we paid a special dividend of $23.7 million, or approximately $1.62 per share, on the Corporation’s common stock, par value $0.10 per shares (the “Common Stock”), in cash and stock to shareholders on May 11, 2020, which distributed all of our accumulated earnings and profits since our inception through 2019. The total amount of cash distributed to all shareholders, as part of the special dividend, was limited to $4.8 million, or 20% of the total special dividend that was paid. The remaining 80% of the special dividend was paid using approximately 8.6 million shares of Common Stock.

The Board of Directors declared a 2020 cash dividend of $1.33 per share on December 21, 2020 that was paid on January 19, 2021 to shareholders of record as of December 31, 2020. The 2020 cash dividend is expected to represent over 90% of our estimated taxable income for 2020.

The Board of Directors declared a quarterly cash dividend of $0.10 per share on February 26, 2021 to shareholders of record as of March 15, 2021. This quarterly cash dividend was paid on March 29, 2021.

To maintain our RIC status, we are required to meet specified source-of-income and asset diversification requirements and distribute annually to our shareholders at least 90% of our ordinary net income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Accordingly, our Board of Directors has initiated a regular quarterly cash dividend, beginning with the cash dividend paid on March 29, 2021.

We intend to co-invest, subject to the conditions included in the exemptive relief order we received from the SEC, with certain of our affiliates. See “SEC Exemptive Order” below. We believe that such co-investments may afford us additional investment opportunities and an ability to achieve greater diversification in our investment portfolio.

SEC Exemptive Order

On October 7, 2020, the Corporation, RCM and certain of their affiliates received exemptive relief from the SEC to permit the Corporation to co-invest in portfolio companies with certain other funds, including other BDCs and registered investment companies, managed by RCM and certain of its affiliates in a manner consistent with the Corporation’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements, subject to compliance with certain conditions (the “Order”). Pursuant to the Order, the Corporation is generally permitted to co-invest with affiliated funds if a “required majority” (as defined in Section 57(o) of the 1940 Act) of the Corporation’s independent directors makes certain conclusions in connection with a co-investment transaction, including that (1) the terms of the transaction, including the consideration to be paid, are reasonable and fair to the Corporation and its shareholders and do not involve overreaching in respect of the Corporation or its shareholders on the part of any person concerned and (2) the transaction is consistent with the interests of the Corporation’s shareholders and is consistent with the Corporation’s investment objective and strategies.

On March 29, 2021, the SEC approved a new exemptive relief order (the “New Order”) reflecting the Adviser Change of Control. This New Order supersedes the Order and permits, subject to compliance with specified conditions, the Corporation to co-invest with affiliates of Callodine. Under the New Order, the Corporation is permitted to co-invest with funds managed by the Adviser and its affiliates under the Adviser’s current ownership structure after the completion of the Adviser Change in Control.

Covid-19 Update

Since the outbreak of the COVID-19 pandemic, our investment adviser, RCM, continues to engage in active discussions with the management teams of the companies within our portfolio regarding actions taken by them for the safety and welfare of their employees and their processes for phasing back to pre-COVID-19 work environments. We also have been informed by RCM about the impact of the COVID-19 induced recession on the businesses of our portfolio companies and the actions the portfolio companies have taken, and are taking, to adapt to changes in demand, both increased and decreased, depending upon the portfolio company. While we do not know what the ultimate impact of the COVID -19 pandemic and the economic downturn will be on our portfolio companies, RCM is actively monitoring our portfolio companies, their liquidity and operational status.

Critical Accounting Policies

We prepare our consolidated financial statements in accordance with United States generally accepted accounting principles (GAAP), which require the use of estimates and assumptions that affect the reported amounts of assets and liabilities. A summary of our critical accounting policies can be found in our Annual Report on Form 10-K for the year ended December 31, 2020 under Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Financial Condition

Overview: March 31, 2021 December 31, 2020 Increase (Decrease) % Increase (Decrease)
Total assets $67,969,156 $60,966,942 $7,002,214 11.5%
Total liabilities 14,091,952 14,862,112 (770,160) (5.2%)
Net assets $53,877,204 $46,104,830 $7,772,374 16.9%

Net asset value per share (NAV) was $20.87 at March 31, 2021 and $17.86 at December 31, 2020.

Our gross outstanding SBA debentures at March 31, 2021 were $11,000,000 and they mature from 2022 through 2029. Cash and cash equivalents approximated 28% of net assets at March 31, 2021, as compared to 44% at December 31, 2020.

Composition of Our Investment Portfolio

Our financial condition is dependent on the success of our portfolio holdings. The following summarizes our investment portfolio at the dates indicated.

March 31, 2021 December 31, 2020 Increase % Increase
Investments, at cost $43,092,765 $40,720,313 $2,372,452 5.8%
Unrealized appreciation (depreciation), net 9,215,220 (671,812) 9,887,032 NA
Investments at fair value $52,307,985 $40,048,501 $12,259,484 30.6%

Our total investments at fair value, as determined by RCM and approved by our Board of Directors, approximated 97% of net assets at March 31, 2021 versus 87% of net assets at December 31, 2020.

With the completion of the Transaction, we changed our investment objectives and strategy. Our new investment objective is to generate current income and, when possible, complement this current income with capital appreciation. As a result, the investments made by Rand since the closing of the Transaction and the investments to be made by Rand in the future are expected to be primarily in higher yielding debt investments and may include public equity in other business development companies that provide income through dividends and relatively more liquidity than our private company investments.

The change in investments during the three months ended March 31, 2021, at cost, is comprised of the following:

New investments: Cost Increase (Decrease)
Seybert’s Billiards Corporation (Seybert’s) $2,800,000
BMP Swanson Holdco, LLC (Swanson) 1,833,333
TCG BDC, Inc. (TCG) 522,753
PennantPark Investment Corporation (PennantPark) 522,082
Apollo Investment Corporation (Apollo) 518,080
FS KKR Capital Corp. (FS KKR) 510,458
Total of new investments 6,706,706
Other changes to investments:
Microcision LLC (Microcision) OID amortization 88,003
Caitec Acquisition, Inc. (Caitec) interest conversion 17,583
Filterworks Acquisition USA, LLC (Filterworks) interest conversion 11,749

40

Seybert’s interest conversion 11,044
HDI Acquisition LLC (Hilton Displays) interest conversion 6,376
Mattison Avenue Holdings LLC (Mattison) interest conversion 5,611
GoNoodle, Inc. (GoNoodle) interest conversion 3,794
SciAps Inc. (Sciaps) OID amortization 3,750
Total of other changes to investments 147,910
Investments repaid, sold, liquidated or converted:
Science and Medicine Group, Inc. (SMG) repayment (1,900,000)
Microcision repayment (1,500,000)
Apollo sale (882,164)
ClearView Social Inc. (ClearView) sale (200,000)
Total of investments repaid, sold, liquidated or converted (4,482,164)
Net change in investments, at cost $2,372,452

Results of Operations

Comparison of the three months ended March 31, 2021 to the three months ended March 31, 2020

Investment Income

Three months ended March 31, 2021 Three months ended March 31, 2020 Increase (Decrease) % Increase (Decrease)
Interest from portfolio companies $710,762 $535,701 $175,061 32.7%
Interest from other investments 12,627 83,250 (70,623) (84.8%)
Dividend and other investment income 246,669 13,125 233,544 1,779.4%
Fee income 46,334 3,750 42,584 1,135.6%
Total investment income $1,016,392 $635,826 $380,566 59.9%

The total investment income that was received on a current basis during the three months ended March 31, 2021 was received from 24 portfolio companies. This contrasts with 13 portfolio companies generating current income during the three months ended March 31, 2020. The number of companies contributing to investment income increased due to the addition of more income generating portfolio companies in the last year.

Interest from portfolio companies – Interest from portfolio companies was approximately 33% higher during the three months ended March 31, 2021 versus the same period in 2020 due to the fact that we originated more income-producing debt investments during the last twelve months. The new debt instruments were originated from Science and Medicine Group Inc. (SMG), Caitec Acquisition, Inc. (Caitec), and Seybert’s Billiards Corporation (Seybert’s). In addition, interest income is higher due to an approximately $88,000 increase in OID income during the three months ended March 31, 2021 due to a first quarter 2021 loan payoff.

The following investment is on non-accrual status: a portion of the Mercantile Adjustment Bureau, LLC (Mercantile) outstanding loan balances.

Interest from other investments – The decrease in interest from other investments is due to lower interest rates received on our cash and cash equivalents, and lower cash balances during the three months ended March 31, 2021versus the same period in 2020.

Dividend and other investment income – Dividend income is comprised of cash distributions from limited liability companies (LLCs) and corporations in which we have invested, including our investment in the shares of publicly held business development companies (BDC). Our investment agreements with certain LLCs require those LLCs to distribute funds to us for payment of income taxes on our allocable share of the LLC’s profits. These portfolio companies may also elect to make additional discretionary distributions. Dividend income will fluctuate based upon the profitability of these LLCs and corporations and the timing of the distributions. The dividend distributions for the respective periods were:

Three months ended March 31, 2021 Three months ended March 31, 2020
Carolina Skiff LLC (Carolina Skiff) $81,801 $—
FS KKR 32,400 —
TCG 31,820 —
Apollo 27,360 —
PennantPark 23,400 —
Tilson Technology Management Inc. (Tilson) 13,125 13,125
Ares Capital Corporation (Ares) 10,800 —
Owl Rock Capital Corporation (Owl Rock) 9,300 —
Golub Capital BDC, Inc. (Golub) 9,063 —
Barings BDC, Inc. (Barings) 7,600 —
Total dividend and other investment income $246,669 $13,125

Fee income – Fee income generally consists of the revenue associated with the amortization of financing fees charged to the portfolio companies upon successful closing of SBIC financings, income from portfolio company board attendance fees and other miscellaneous fees. The financing fees are amortized ratably over the life of the instrument associated with the fees. The unamortized fees are carried on the balance sheet under the line item “Deferred revenue.”

The income associated with the amortization of financing fees was $16,334 and $3,750 for the three months ended March 31, 2021 and 2020, respectively. During the three months ended March 31, 2021, the Corporation recognized a one-time fee of $30,000 in conjunction with the repayment of the Microcision loan instrument. There were no board fees for the three months ended March 31, 2021 or 2020.

Expenses

Three months ended March 31, 2021 Three months ended March 31, 2020 Increase % Increase
Total expenses $3,165,663 $516,506 $2,649,157 513%

Expenses increased approximately $2,650,000 during the three months ended March 31, 2021 compared to the three months ended March 31, 2020. The increase in operating expenses was primarily due to a $2,600,000 increase in capital gains incentive fees and an approximately $35,000 increase in the base management fee payable to RCM. The increase in capital gains incentive fees is due to our accrual during the three months ended March 31, 2021 of a capital gains incentive fee, which accrual results from a requirement of GAAP. The Investment Management Agreement does not allow the use of unrealized gains in calculating the amount of the capital gains incentive fee payable under such agreement. However, as required by GAAP, the Corporation must accrue capital gains incentive fees on the basis of unrealized gains. This capital gains incentive fee accrual reflects the capital gains incentive fees that would be payable to RCM if our entire investment portfolio was liquidated at its fair value as of the balance sheet date even though RCM is not entitled to a capital gains incentive fee with respect to unrealized gains unless and until such gains are actually realized. There were no incentive fees accrued for the three months ended March 31, 2020.

The base management fee is calculated on total assets less cash, and, as we deploy more capital into investments, the base management fee will increase accordingly.

In November 2019, we completed a stock sale transaction with East and concurrently externalized the management of our portfolio to Rand Capital Management, LLC (RCM) as our external investment adviser and administrator. Our primary operating expenses now include the payment of fees to RCM under the

Investment Management Agreement, and our allocable portion of overhead expenses and other administrative expenses under the Administration Agreement with RCM. Under the terms of the Investment Management Agreement, the compensation of the investment professionals of RCM and its staff, and the general office and overhead expenses incurred by RCM in maintaining its place of business, will be provided, and paid for by RCM and not by us. We will be responsible for all other operating expenses, including those relating to:

(i) organization;
(ii) costs of calculating our net asset value (including the cost and expenses of any independent valuation firm);
(iii) expenses incurred by RCM payable to third parties, including agents, consultants or other advisors, in monitoring financial and legal affairs and in monitoring our investments and performing due diligence on its prospective portfolio companies;
(iv) interest payable on debt, if any, incurred to finance our investments;
(v) offerings of our Common Stock and other securities;
(vi) investment advisory and management fees payable under the Investment Management Agreement, but excluding any fees payable to any Sub-Adviser;
(vii) administration fees payable under the Administration Agreement;
(viii) transfer agent and custodial fees;
(ix) federal and state registration fees;
(x) all costs of registration and listing our shares on any securities exchange;
(xi) federal, state and local taxes;
(xii) independent directors’ fees and expenses;
(xiii) costs of preparing and filing reports or other documents required by governmental bodies (including the SEC);
(xiv) costs of any reports, proxy statements or other notices to shareholders, including printing costs;
(xv) our allocable portion of the fidelity bond, directors and officers/errors and omissions liability insurance, and any other insurance premiums;
(xvi) direct costs and expenses of administration, including independent auditors and outside legal costs; and
(xvii) all other expenses incurred by us or RCM in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the RCM’s overhead in performing its obligations under the Administration Agreement, including rent and the allocable portion of the cost of our chief financial officer and chief compliance officer and their respective staffs (including travel expenses)).

Net Investment Income

The excess of investment income over total expenses represents net investment income (or loss). The net investment (loss) income for the three months ended March 31, 2021 and 2020 was ($2,167,028) and $538,421, respectively.

Realized Gain on Investments

Three months ended March 31, 2021 Three months ended March 31, 2020 Change
Realized gain on investments before income taxes $310,755 $2,393,451 ($ 2,082,696)

During the three months ended March 31, 2021, we sold our shares in Apollo Investment Corporation and recognized a gain of approximately $175,000. In addition, we sold our investment in ClearView Social, Inc. and realized an approximately $135,000 gain.

During the three months ended March 31, 2020, we realized a $2.3 million gain when we exited our investment in Outmatch. We also received additional proceeds of $56,916 from Microcision LLC (Microcision) related to the 2019 sale of our equity interest in Microcision and $39,000 in additional gain from Advantage 24/7.

Change in Unrealized Depreciation of Investments

Three months ended March 31, 2021 Three months ended March 31, 2020 Change
Change in unrealized depreciation of investments before income taxes $9,887,032 ($ 728,323) $10,615,355

43

The change in unrealized depreciation, before income taxes, for the three months ended March 31, 2021, was comprised of the following:

Three months ended March 31, 2021
ACV Auctions, Inc. (ACV) $9,287,855
TCG BDC, Inc. (TCG) 209,240
FS KKR Capital Corp. (FS KKR) 142,005
PennantPark Investment Corporation (Pennantpark) 103,451
Ares Capital Corporation (Ares) 54,900
Owl Rock Capital Corporation (Owl Rock) 38,100
Barings BDC, Inc. (Barings) 32,534
Golub Capital BDC, Inc. (Golub) 26,563
Apollo Investment Corporation (Apollo) (7,616)
Total change in net unrealized appreciation (depreciation) of investments before income taxes $9,887,032

Ares, Barings, FS KKR, Golub, Owl Rock, Pennantpark and TCG are all publicly traded stocks, and as such, are marked to market at the end of each quarter. We sold our Apollo shares during the three months ended March 31, 2021.

ACV completed an Initial Public Offering (IPO) at $25.00 per share on March 23, 2021 trading on the NASDAQ Global Select market under the symbol “ACVA”. We owned 590,580 shares of common stock of ACV prior to the IPO. ACV, as a publicly traded stock, was marked to market at the end of the first quarter. The stock was valued at a three-day average bid price and was discounted due to trading restrictions on the stock which expire no later than September 20, 2021. The Corporation valued its 590,580 shares of ACV at $26.79 at March 31, 2021.

The change in unrealized depreciation, before income taxes, for the three months ended March 31, 2020 was comprised of the following:

Three months ended March 31, 2020
Owl Rock Capital Corporation (Owl Rock) ($ 1,367)
Golub Capital BDC, Inc. (Golub) (30,597)
FS KKR Capital Corp. (FS KKR) (26,647)
Ares Capital Corporation (Ares) (49,070)
Apollo Investment Corporation (Apollo) (110,451)
Genicon, Inc. (Genicon) (510,191)
Total change in net unrealized depreciation of investments before income taxes during the three months ended March 31, 2020 ($ 728,323)

The valuation of our investment in Genicon, during the three months ended March 31, 2020, was decreased after a review of their operations and financial condition.

Apollo, Ares, FS KKR, Golub and Owl Rock are all publicly traded stocks, and as such, are marked to market at the end of each quarter.

All of these value adjustments resulted from a review RCM management using the guidance set forth by ASC 820 and our established valuation policy.

Net Increase in Net Assets from Operations

The net increase in net assets from operations on our consolidated statements of operations for the three months ended March 31, 2021 and 2020, $8,030,759 and $430,137, respectively.

Liquidity and Capital Resources

With the completion of the Transaction with East, we changed our investment objectives and strategy. Previously, our principal investment objective was to achieve long-term capital appreciation on our equity investments while maintaining a current cash flow from debenture and pass-through equity instruments to fund expenses. With our plan to elect U.S. federal tax treatment as a RIC, our new investment objective is to generate current income and, when possible, complement this current income with capital appreciation. As a result, our recent and future investments are expected to be made primarily in yield generating investments and may include related equity options, such as warrants or preferred equity.

As of March 31, 2021, our total liquidity consisted of approximately $14,900,000 in cash and cash equivalents. In addition, we had an outstanding SBA leverage commitment of $3,000,000.

Net cash provided by operating activities has averaged approximately $75,000 per year over the last three years. The cash used for investments in portfolio companies has averaged approximately $7,600,000 per year over the last three years. We will generally use cash to fund our operating expenses, invest in portfolio companies, pay dividends and repurchase shares. We anticipate that we will continue to exit investments and shift our portfolio to income producing investments. However, the timing of liquidation events within the portfolio is difficult to project. Starting in 2022 (See Note 6 in the Notes to the Consolidated Financial Statements), our outstanding SBA debt begins to mature, and this will require us to identify sources of future funding if liquidation of investments is not sufficient to fund operations and repay the SBA debt obligation.

We believe that the cash on hand at March 31, 2021, the undrawn SBA leverage commitment and the scheduled interest payments on our portfolio investments will be sufficient to meet our cash needs throughout 2021. We continue to pursue current income and distributions from portfolio companies to increase the liquidity available for new investments, operating expenses, dividends and future SBA debenture obligations.

Our ongoing liquidity is tied to the performance of our portfolio companies and, as such, it may be affected going forward based on the impact of the COVID-19 pandemic and its lasting impact on the capital markets, our portfolio companies, and the U.S. economy in general.

Market risk

As filed, 1,864 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our investment activities contain elements of risk. Our investment portfolio consists of equity and debt securities in private companies and is subject to valuation risk. Because there is typically no public market for the equity and debt securities in which we invest, the valuation of the equity interests in the portfolio is stated at “fair value” as determined in good faith by RCM and approved by our Board of Directors. This is in accordance with our investment valuation policy (see the discussion of valuation policy contained in “Note 3. Investments” in the consolidated financial statements contained in Item 1 of this report, which is hereby incorporated herein by reference.) In the absence of readily ascertainable market values, the estimated value of investments in our portfolio may differ significantly from the values that would be placed on such investments in our portfolio if a ready market for the investments existed. Any changes in valuation are recorded on the consolidated statement of operations as “Net change in unrealized depreciation on investments.”

At times, a portion of our portfolio may include, and does currently include, marketable securities traded in the over-the-counter market or on other stock markets. In addition, there may be a portion of the portfolio for which no regular trading market exists. In order to realize the full value of a security, the market must trade in an orderly fashion or a willing purchaser must be available when a sale is to be made. Should an economic or other event occur that would not allow markets to trade in an orderly fashion, we may not be able to realize the fair value of our marketable investments or other investments in a timely manner.

As of March 31, 2021, we did not have any off-balance sheet arrangements or hedging or similar derivative financial instrument investments.

Controls and procedures

As filed, 1,365 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Disclosure Controls and Procedures. The Corporation maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that this information is accumulated and communicated to management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Chief Executive Officer and the Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of the Corporation’s disclosure controls and procedures as of March 31, 2021. Based on the evaluation of these disclosure controls and procedures, the Chief Executive Officer and Chief Financial Officer concluded that the Corporation’s controls and procedures were effective as of March 31, 2021.

Changes in Internal Control over Financial Reporting. There have been no changes in our internal control over financial reporting during the Corporation’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Corporation’s internal control over financial reporting.

PART II.

OTHER INFORMATION

Risk factors

As filed, 133 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

See the information provided under the heading “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2020.

Source: SEC EDGAR, the filing index for accession 0001193125-21-155675. Last ingested by Listed: Nov 4, 2026, 08:48 ET. Listed shows no prices and gives no investment advice.